Too many older people with HIV taking medicines they may not need
Cabotegravir levels lower than trials in real-world study, but no increase in viral rebound
Dolutegravir-based triple therapy effectively suppresses HIV-2 viral load in small study
Higher anal cancer mortality for women with HIV
PrEP marketing should not be a story about HIV, but a story about young women
Substance use treatment effective in helping men reduce their use of crystal meth
Migrants being left behind by the HIV response in Europe
Greater income inequality linked to worse HIV outcomes
Multiple strategies needed to reduce disengagement from HIV care in Uganda
